HBM Healthcare Investments (Cayman) Ltd. - 08 Oct 2025 SCHEDULE 13G Report for ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share (AVBP)

Filing Manager: HBM Healthcare Investments (Cayman) Ltd.
Reporting Manager: HBM Healthcare Investments (Cayman) Ltd.
Security: ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share
Symbol: AVBP
Shares outstanding: 40.6M shares
Disclosed Ownership: 2.2M shares
Ownership: 5.4%
Form type: SCHEDULE 13G
Filing time: 15 Oct 2025, 16:07:02 UTC
Date of event: 08 Oct 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
HBM Healthcare Investments (Cayman) Ltd.	5.4%	2.2M	2.2M	0	/s/ Jean-Marc LeSieur	Jean-Marc LeSieur, Managing Director